C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2006
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863778A Compounds and methods for treating dyslipidemia
11/15/2006	CN1863534A Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases
11/15/2006	CN1861604A Crystal form of asenapine maleate
11/15/2006	CN1861598A Preparation process of thiatro bromoaminium anhydrous compound
11/15/2006	CN1284781C Polycyclic compounds having anti-tumor activity
11/15/2006	CN1284536C Application of tetrodotoxin or saxitionxin and analogs thereof in preparation of general antalgic medicine application
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135570 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135479 Compounds which are both serotonin reuptake inhibitors and antagonists of the 5HT1A receptor
11/14/2006	US7135478 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
11/14/2006	US7135470 Thienopyridazines as IKK inhibitors
11/14/2006	US7135468 Antibacterial compounds
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006117383A1 Terrylene and quaterrylene derivatives
11/09/2006	WO2006117316A1 Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
11/09/2006	WO2006117304A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
11/09/2006	WO2006074293A3 Bicyclic dihydropyrimidines as eg5 inhibitors
11/09/2006	WO2006019673A3 Jiadifenin analogs and uses thereof
11/09/2006	US20060252931 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/09/2006	US20060252812 1'-(2-cyclopropylethyl)spiro[furo[2,3-f][1,3]benzodioxole-7,3'-indol]-2'(1'H)-one; for treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain
11/09/2006	US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006	US20060252759 (5R,8aR)-5-methyl-1,3,5,6,7,8,8a,9-octahydro-2-oxa-4,4b,7-triaza-cyclopenta[b]fluorene; serotonin (5HT2C) receptor agonists; reductiv amination, acylation
11/09/2006	DE102005021362A1 Terrylen- und Quaterrylenderivate Terrylene- and quaterrylene
11/09/2006	CA2605900A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity
11/08/2006	EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006	EP1719774A2 Preventive or therapeutic agent for diabetic maculopathy
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1718653A1 Glucocorticoid receptor modulator compounds and methods- utility
11/08/2006	EP1718604A1 Immunosuppressant compounds and compositions
11/08/2006	EP1718299A1 Heterocyclic gaba-a subtype selective receptor modulators
11/08/2006	EP1587810B1 Novel substituted 1,4\|benzodioxino 2,3-e\|isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
11/08/2006	EP1419155B1 Piperidine derivatives as antibacterial agents
11/08/2006	CN1860117A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/08/2006	CN1859949A New derivative of 4A,5,9,10,11,12-tetrahydro-6H-benzofuro[3A, 3, 2-EF] [2] benzazepinium bromide, method of preparation thereof and use in the production of medicaments
11/08/2006	CN1858051A Process for preparing 2-ethyl-2[6-cyano-1,1-(ethylidenedioxy)-5-oxy-1,2,3,5-tetrahydro-indolelidine]-ethyl acetate
11/08/2006	CN1283975C Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer
11/08/2006	CN1283643C Preparation of S-tricyctic lactone
11/07/2006	US7132540 Hindered spiro-ketal nitroxides
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132430 Treatment of cardiovascular and related pathologies
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/02/2006	WO2006116727A2 Compositions and methods for detection of sirolimus
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006114606A1 Fused thiazole derivatives as kinase inhibitors
11/02/2006	WO2006067224A3 Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
11/02/2006	WO2006067092A3 Stereoselective process and crystalline forms of a camptothecin
11/02/2006	WO2006061392A3 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247217 Tricyclic protein kinase inhibitors
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247211 Cytotoxic indeno and isoindoloisoquinolones
11/02/2006	US20060246518 Compositions and methods for detection of sirolimus
11/02/2006	US20060246009 Novel Crystalline Forms of Tiotropium Bromide
11/02/2006	EP1716145A1 Dihydrotetrabenazines and pharmaceutical compositions containing them
11/02/2006	EP1716142A2 Oxazole derivatives, preparation and therapeutic use therof
11/02/2006	EP1315700B1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	CA2607426A1 Fused thiazole derivatives as kinase inhibitors
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/01/2006	CN1856498A Thienopyridine and furopyridine kinase inhibitors
11/01/2006	CN1856497A Ligands
11/01/2006	CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/01/2006	CN1282644C Indane or indoline derivative
10/2006
10/31/2006	US7129355 Process for preparing kifunensine intermediate and kifunensine therefrom
10/31/2006	US7129266 its production by fermentation, to methods for its recovery and concentration from the crude solutions, and to a process for its purification
10/31/2006	US7129262 Effective to reduce the viability and/or to sensitize the cancer to an anti-cancer agent.
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006	US7129093 Quantitative method of determining beryllium or a compound thereof in a sample
10/31/2006	CA2262796C 4-substituted beta-carbolines as immunomodulators
10/26/2006	WO2006111849A1 Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	WO2006065448A3 Topoisomerase inhibitors and prodrugs
10/26/2006	US20060241299 Process for making spirolactone compounds
10/26/2006	US20060241168 administering a protein kinase B activating agent comprising (R)-5,6-dimethoxy-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline; treating depression, posttraumatic stress disorder, Parkinson's disease, Alzheimer's diseases
10/26/2006	US20060241151 Pyrid-2-one derivatives and methods of use
10/26/2006	US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis
10/26/2006	US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
10/26/2006	US20060241100 Acylaminobicyclic heteroaromatic compounds and uses thereof
10/26/2006	CA2605479A1 Acylaminobicyclic heteroaromatic compounds and uses thereof
10/25/2006	EP1713814A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators
10/25/2006	EP1713790A2 Method of preparation of benzofuran-2-carboxylic acid (s)-3-methyl-1- ((4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-az epan-4-ylcarbamoyl-butyl)-amide
10/25/2006	EP1669357A4 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof
10/25/2006	EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
10/25/2006	EP1313476B1 Sgk3 used as diagnostic and therapeutic target
10/25/2006	CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia
10/25/2006	CN1850824A Benzene-free tetrandrine and its preparing method
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126000 via a 5-hydroxy-2-nitrobenzaldehyde intermediate
10/24/2006	US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006	US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization

1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 298